While Individual Investors Own 30% of Shanghai Shyndec Pharmaceutical Co., Ltd. (SHSE:600420), Private Companies Are Its Largest Shareholders With 58% Ownership

Simply Wall StFeb 13 18:04 ET

Shyndec Pharma's Units Get Three Drug Registration Certificates

MT NewswiresJan 22 05:40 ET

Shanghai Shyndec's Shenzhen Unit Passes EU GMP Inspection

MT NewswiresJan 20 00:42 ET

Shyndec Pharma Unit's Cefuroxime Sodium for Injection Passes Regulatory Consistency Evaluation

MT NewswiresJan 20 00:23 ET

Sinopharm Hyundai: 2024 Annual Performance Forecast

SZSIJan 19 11:00 ET · Announcements

2024 Annual Results Forecast

SZSIJan 19 11:00 ET · Announcements